Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(14%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
2
29%
Ph not_applicable
1
14%
Ph phase_2
1
14%
Ph phase_3
1
14%
Ph phase_1
2
29%

Phase Distribution

2

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
2(28.6%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (28.6%)
Phase 21 (14.3%)
Phase 31 (14.3%)
Phase 42 (28.6%)
N/A1 (14.3%)

Trials by Status

recruiting114%
unknown114%
withdrawn114%
completed457%

Recent Activity

1 active trials
Showing 5 of 7
completedphase_4

Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery

NCT07374445
recruitingphase_3

Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery

NCT06361238
withdrawnphase_2

Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia

NCT04683237
completedphase_4

Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery

NCT06201819
unknownnot_applicable

POSE2.0 With GLP-1 Agonist for Obesity Management

NCT05705388
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07374445Phase 4

Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery

Completed
NCT06361238Phase 3

Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery

Recruiting
NCT04683237Phase 2

Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia

Withdrawn
NCT06201819Phase 4

Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery

Completed
NCT05705388Not Applicable

POSE2.0 With GLP-1 Agonist for Obesity Management

Unknown
NCT05225974Phase 1

A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects

Completed
NCT05029076Phase 1

Human Bioequivalence Test of Liraglutide Injection

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7